Daiichi Sankyo Korea, Daewoong to co-market Sevikar HCT

Published: 2013-02-06 06:56:00
Updated: 2013-02-06 06:56:00
Daiichi Sankyo Korea and Daewoong Pharma on Monday announced that the two companies have signed an agreement to co-market Sevikar HCT tablets here.

Sevikar HCT, which contains three active ingredients, amlodipine, olmesartan and hydrochlorothiazide, is the first three-in-one pill to treat hype...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.